Phantom Neuro (Series A)
Funding Details
Awarder
Inbox
Date Award
April 15, 2025
Vertical
Biotech and Health
Funding URL
View Funding Page
Funding Amount
$19,000,000
Company Info
Traction
Phantom Neuro has received FDA Breakthrough Device and TAP designations, indicating significant progress in its path to commercialization.
Founders
Dr. Connor Glass
Market
Medical Technology for Amputees
Location
Austin, California, USA
Coinvestors
Ottobock, Breakout Ventures, Draper Associates, LionBird Ventures, Time BioVentures, Risk and Return, Actual VC, METIS Innovative, E1 Ventures, Jumpspace, MainSheet Ventures, Brown Advisory, Johns Hopkins, Intel
Company Description

Phantom Neuro develops muscle-machine interfaces for robotic limb rehabilitation solutions.

Links
WebsiteCrunchbaseLinkedInTwitter
Back to HomeBack to Biotech and Health DealsView Funding Announcement